Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CM9241GRU in Perennial Allergic Rhinitis
NCT06577077Phase 3Not yet recruiting
- Sponsor
- Aché Laboratórios Farmacêuticos
- Start
- Sep 2024
- Primary completion
- Aug 2025
- Modality
- Small Molecules
01
Overview
A Phase 3 trial of brompheniramine, phenylephrine in perennial allergic rhinitis (PAR), sponsored by Aché Laboratórios Farmacêuticos. Planned start Sep 2024; status: not yet recruiting.
02
Drugs
brompheniraminephenylephrine
03
Conditions
perennial allergic rhinitis (PAR)
Beyond the preview
Go deeper on NCT06577077.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06577077.